Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with …

D Schulthess, D Gassull, A Makady… - BMJ Evidence-Based …, 2021 - ebm.bmj.com
With the increasing use of new regulatory tools, like the Food and Drug Administration's
breakthrough designation, there are increasing challenges for European health technology …

Electrochemical sensing of membrane potential and enzyme function using gallium arsenide electrodes functionalized with supported membranes

D Gassull, A Ulman, M Grunze… - The Journal of Physical …, 2008 - ACS Publications
We deposit phospholipid monolayers on highly doped p-GaAs electrodes that are precoated
with methyl-mercaptobiphenyl monolayers and operate such a biofunctional electrolyte …

[HTML][HTML] The relative contributions of NIH and private sector funding to the approval of new biopharmaceuticals

D Schulthess, HP Bowen, R Popovian… - … Innovation & Regulatory …, 2023 - Springer
Objectives There remains ongoing debate regarding the relative efficacy of public (NIH) and
private sector funding in bringing biopharmaceutical innovations to market. This paper …

Unlocking the value of personalised healthcare in Europe—breast cancer stratification

W Van Dyck, D Gassull, G Vértes, P Jain… - Health policy and …, 2012 - Elsevier
Through stratification, this simulation shows that there is great potential to improve the
efficiency of treating breast cancer. By segmenting the female population at the age of 50 …

Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?

W Van Dyck, G Vértes, M Palaniappan… - Health Policy and …, 2012 - Elsevier
This study is a cost-analysis that calculates the impact of three interventions for patients
identified as 'at risk'for Acute Coronary Syndrome-a cardio-vascular exercise programme …

PH sensitivity of gallium arsenide (GaAs) electrodes functionalized with methyl− mercaptobiphenyl monolayers

D Gassull, SM Luber, A Ulman, M Grunze… - The Journal of …, 2007 - ACS Publications
GaAs electrodes coated with hydrophobic, methyl− mercaptobiphenyl (CH3− MBP)
monolayers exhibited an excellent electrochemical stability. We found that the interface …

Tying medicare part B drug prices to international reference pricing will devastate R&D

D Schulthess, D Gassull… - Therapeutic Innovation & …, 2019 - journals.sagepub.com
According to Secretary Azar of Health and Human Services, implementing international
reference pricing (IPI) in Medicare Part B will have minimal impacts. He has stated,“These …

Whole-Body Magnetic Resonance Angiography (WBMRA) as a tool for driving efficiency in the cost and treatment of Claudication Co-morbities

D Gassull, D Schulthess, S Suttie, G Houston - Health Policy and …, 2013 - Elsevier
Abstract The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a
contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a …

Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals

D Schulthess, HP Bowen, R Popovian… - … Innovation & Regulatory …, 2023 - Springer
Analysis and results, paragraph 1-the phrase “$2415 billion” should read “$2.415 billion”.
The phrase “$50,671 billion” should read “$50.671 billion”. The phrase “$91,256 billion” …

[CITATION][C] Health for all, care for you: Unlocking the value of personalized healthcare in Europe

W Van Dyck, D Gassull, G Vértes, P Jain… - 2012 - repository.vlerick.com
Health for all, care for you: Unlocking the value of personalized healthcare in Europe
Toggle navigation Login Toggle navigation View Item Vlerick Repository Home Research …